Juventas Therapeutics raises $13.5M

What does Juventas Therapeutics do?

Juventas Therapeutics, is a clinical stage biotechnology company which develops regenerative therapies to treat life threatening diseases. This private clinical stage biotech company is developing a pipeline of regenerative therapies to treat life threatening diseases. It has exclusive license from the Cleveland clinic, and transitioned from its platform from concept to initiation of mid stage clinical trials.

It develops non-viral gene therapies for treating advance cardiovascular diseases.

How much Juventas Therapeutics was funded?

Juventas Therapeutics raised $13.5M in Series B funding on May 12^th, 2015 from POSCO Venture Capital and Green Cross. The funding involved existing and new investors.

Previous funding

• $300k in Seed round on September 30, 2008 from JumpStart Inc.
• $22.2M in Series B funding on July 16^th, 2012 from North Coast Angel Fund, Takeda Ventures, Venture Investors, New Science Ventures, Fletcher Spaght Ventures and Early Stage Partners.
• $5M in Venture round on November 20^th, 2013.

What is next for Juventas Therapeutics?

Juventas Therapetuics is confident that it is to secure another $9M if certain milestones are met. Its upcoming studies will evaluate the use of JV-100 therapy for treating patients with late stage peripheral artery disease and for patients with chronic heart failure. The financing will help the company to lay the groundwork for initiating multiple Phase 2b clinical studies.

More about Juventas Therapeutics

Juventas Therapeutics was founded on January 1^st, 2007 by Marc Penn and Rahul Aras. It has its headquarters in Cleveland, OH.  This is a 2007 private clinical stage company developing novel therapies for ischemic cardiovascular disease. It has an exclusive license from Cleveland clinic. This has transformed its therapeutic platform from concept into phase II clinical trials for critical limb ischemia and heart failure. Its lead product is JVS-100, which is a non-viral plasmid which encodes for cell-derived factor- 1.